<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=%CE%944-Tibolone</id>
	<title>Δ4-Tibolone - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=%CE%944-Tibolone"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%CE%944-Tibolone&amp;action=history"/>
	<updated>2026-04-12T14:38:29Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=%CE%944-Tibolone&amp;diff=49978&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%CE%944-Tibolone&amp;diff=49978&amp;oldid=prev"/>
		<updated>2025-03-18T10:35:27Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:35時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49977:rev-49978 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=%CE%944-Tibolone&amp;diff=49977&amp;oldid=prev</id>
		<title>bsd&gt;JJMC89 bot III: Moving :Category:Androgens and anabolic steroids to :Category:Anabolic–androgenic steroids per Wikipedia:Categories for discussion/Log/2023 October 29#Category:Androgens and anabolic steroids</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%CE%944-Tibolone&amp;diff=49977&amp;oldid=prev"/>
		<updated>2023-11-11T17:50:41Z</updated>

		<summary type="html">&lt;p&gt;Moving &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:Androgens_and_anabolic_steroids&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:Androgens and anabolic steroids (存在しないページ)&quot;&gt;Category:Androgens and anabolic steroids&lt;/a&gt; to &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:Anabolic%E2%80%93androgenic_steroids&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:Anabolic–androgenic steroids (存在しないページ)&quot;&gt;Category:Anabolic–androgenic steroids&lt;/a&gt; per &lt;a href=&quot;http://en.wikipedia.org/wiki/Categories_for_discussion/Log/2023_October_29#Category:Androgens_and_anabolic_steroids&quot; class=&quot;extiw&quot; title=&quot;wikipedia:Categories for discussion/Log/2023 October 29&quot;&gt;Wikipedia:Categories for discussion/Log/2023 October 29&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = &lt;br /&gt;
| Watchedfields = &lt;br /&gt;
| verifiedrevid = &lt;br /&gt;
| IUPAC_name = (7&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,8&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,9&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,10&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,13&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,14&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,17&amp;#039;&amp;#039;R&amp;#039;&amp;#039;)-17-Ethynyl-17-hydroxy-7,13-dimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[&amp;#039;&amp;#039;a&amp;#039;&amp;#039;]phenanthren-3-one&lt;br /&gt;
| image = Δ4-Tibolone.svg&lt;br /&gt;
| width = 225px&lt;br /&gt;
| image2 = Δ4-Tibolone molecule ball.png&lt;br /&gt;
| width2 = 235px&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &lt;br /&gt;
| legal_UK = &lt;br /&gt;
| legal_US = &lt;br /&gt;
| legal_status = &lt;br /&gt;
| routes_of_administration = &lt;br /&gt;
| class = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| CAS_number = 1162-60-3&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = LHZ8R2OW0M&lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
| ATC_supplemental = &lt;br /&gt;
| PubChem = 22814761&lt;br /&gt;
| IUPHAR_ligand = &lt;br /&gt;
| DrugBank_Ref = &lt;br /&gt;
| DrugBank = &lt;br /&gt;
| ChemSpiderID_Ref = &lt;br /&gt;
| ChemSpiderID = 18532860&lt;br /&gt;
| KEGG = &lt;br /&gt;
| ChEBI = &lt;br /&gt;
| ChEMBL = &lt;br /&gt;
| synonyms = ORG-OM-38; Delta-4-Tibolone; 7α-Methylnorethisterone; 7α-Methyl-17α-ethynyl-19-nortestosterone; 17α-Ethynyl-17β-hydroxy-7α-methyl-4-estren-3-one&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=21 | H=28 | O=2&lt;br /&gt;
| SMILES = C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O&lt;br /&gt;
| StdInChI_Ref = &lt;br /&gt;
| StdInChI = 1S/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,12-13,16-19,23H,5-11H2,2-3H3/t13-,16+,17-,18+,19-,20+,21+/m1/s1&lt;br /&gt;
| StdInChIKey_Ref = &lt;br /&gt;
| StdInChIKey = WAOKMNBZWBGYIK-KIURNNQRSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;δ&amp;lt;sup&amp;gt;4&amp;lt;/sup&amp;gt;-Tibolone&amp;#039;&amp;#039;&amp;#039; (developmental code name &amp;#039;&amp;#039;&amp;#039;ORG-OM-38&amp;#039;&amp;#039;&amp;#039;), also known as &amp;#039;&amp;#039;&amp;#039;7α-methylnorethisterone&amp;#039;&amp;#039;&amp;#039; or as &amp;#039;&amp;#039;&amp;#039;7α-methyl-17α-ethynyl-19-nortestosterone&amp;#039;&amp;#039;&amp;#039;, is a [[synthetic compound|synthetic]] [[androgen]] and [[progestin]] which was never marketed.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot;&amp;gt;{{cite journal | vauthors = Kuhl H | title = Pharmacology of estrogens and progestogens: influence of different routes of administration | journal = Climacteric | volume = 8 | pages = 3–63 | year = 2005 | issue = Suppl 1 | pmid = 16112947 | doi = 10.1080/13697130500148875 | s2cid = 24616324 | url = http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid19464167&amp;quot;&amp;gt;{{cite journal | vauthors = Escande A, Servant N, Rabenoelina F, Auzou G, Kloosterboer H, Cavaillès V, Balaguer P, Maudelonde T | title = Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites | journal = J. Steroid Biochem. Mol. Biol. | volume = 116 | issue = 1–2 | pages = 8–14 | year = 2009 | pmid = 19464167 | doi = 10.1016/j.jsbmb.2009.03.008 | s2cid = 18346113 | url = http://www.hal.inserm.fr/inserm-00396319/document}}&amp;lt;/ref&amp;gt; The compound is a major [[active metabolite]] of [[tibolone]], which itself is a [[prodrug]] of δ&amp;lt;sup&amp;gt;4&amp;lt;/sup&amp;gt;-tibolone along with [[3α-hydroxytibolone]] and [[3β-hydroxytibolone]] (which, in contrast to δ&amp;lt;sup&amp;gt;4&amp;lt;/sup&amp;gt;-tibolone, are [[estrogen (medication)|estrogen]]s).&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt; Tibolone and δ&amp;lt;sup&amp;gt;4&amp;lt;/sup&amp;gt;-tibolone are thought to be responsible for the androgenic and progestogenic activity of tibolone, while 3α-hydroxytibolone and 3β-hydroxytibolone are thought to be responsible for its [[estrogen (medication)|estrogenic]] activity.&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[List of androgens/anabolic steroids]]&lt;br /&gt;
* [[List of progestogens]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Androgen receptor modulators}}&lt;br /&gt;
{{Progesterone receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
{{DISPLAYTITLE:δ&amp;lt;sup&amp;gt;4&amp;lt;/sup&amp;gt;-Tibolone}}&lt;br /&gt;
&lt;br /&gt;
{{DEFAULTSORT:Tibolone, delta4-}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Abandoned drugs]]&lt;br /&gt;
[[Category:Tertiary alcohols]]&lt;br /&gt;
[[Category:Alkene derivatives]]&lt;br /&gt;
[[Category:Ethynyl compounds]]&lt;br /&gt;
[[Category:Anabolic–androgenic steroids]]&lt;br /&gt;
[[Category:Estranes]]&lt;br /&gt;
[[Category:Human drug metabolites]]&lt;br /&gt;
[[Category:Ketones]]&lt;br /&gt;
[[Category:Progestogens]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Genito-urinary-drug-stub}}&lt;br /&gt;
{{Steroid-stub}}&lt;/div&gt;</summary>
		<author><name>bsd&gt;JJMC89 bot III</name></author>
	</entry>
</feed>